Status:
UNKNOWN
Establishment of Special Disease Cohort for RPLand Study of Impact Mechanism of Early Embryo Development
Lead Sponsor:
Women's Hospital School Of Medicine Zhejiang University
Conditions:
Recurrent Pregnancy Loss
Eligibility:
FEMALE
18-50 years
Brief Summary
Recurrent pregnancy loss (RPL) is a refractory disease with diverse etiologies, complex pathogenesis and limited therapeutic options. Current tests and treatments lack uniform specifications. This stu...
Detailed Description
Objective: (1) to establish a prediction model of pregnancy outcome and apply it to clinical practice; (2) to standardize the diagnosis and treatment of RPL. This study is an observational study. The...
Eligibility Criteria
Inclusion
- (1) patients who were treated in the outpatient department of Zhejiang University Women's Hospital from January 1, 2018 to December 31, 2020;
- (2) With history of once spontaneous abortion;
- (3) Having fertility requirements but not yet pregnant;
- (4) Those who are willing to give birth again during the study period.
Exclusion
- (1) Previous history of multiple spontaneous abortion, inevitable abortion or missed abortion;
- (2) Re pregnancy after abortion, now in pregnancy or delivered;
- (3) Patients who are participating in other clinical studies or those who refuse to participate in the study;
- (4) The researchers consider that she is not suitable to participate in this study for other reasons.
Key Trial Info
Start Date :
January 12 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT05186207
Start Date
January 12 2022
End Date
December 31 2024
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women's Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China